aluates Reports

$ 0.0

Automative

Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-12J7402

China Imatinib Mesylate Drugs Market Report Forecast 2021 2027

BUY CHAPTERS

Imatinib Mesylate Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-12J7402

Report

September 2024

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Imatinib Mesylate Drugs - Market Size

The global market for Imatinib Mesylate Drugs was estimated to be worth US$ 341 million in 2023 and is forecast to a readjusted size of US$ 595.2 million by 2030 with a CAGR of 8.5% during the forecast period 2024-2030

Imatinib Mesylate Drugs - Market

Imatinib is a medication used to treat cancer.

For many patients with CML and GIST, Gleevec became a long-term treatment to manage their condition effectively. This sustained demand was driven by the need for ongoing therapy to control cancer progression.

Over time, Gleevec's efficacy in other cancers or its potential use in combination with other treatments may have led to an increase in demand for off-label or investigational uses.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Imatinib Mesylate Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Imatinib Mesylate Drugs by region & country, by Type, and by Application.

The Imatinib Mesylate Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imatinib Mesylate Drugs.

Market Segmentation

Scope of Imatinib Mesylate Drugs - Market Report

Report Metric	Details
Report Name	Imatinib Mesylate Drugs - Market
Forecasted market size in 2030	US$ 595.2 million
CAGR	8.5%
Forecasted years	2024 - 2030
Segment by Type:	100mg 400mg
Segment by Application	Hospital Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Imatinib Mesylate Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Imatinib Mesylate Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Imatinib Mesylate Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Imatinib Mesylate Drugs - Market size in 2030?

Ans: The Imatinib Mesylate Drugs - Market size in 2030 will be US$ 595.2 million.

Who are the main players in the Imatinib Mesylate Drugs - Market report?

Ans: The main players in the Imatinib Mesylate Drugs - Market are Novartis

What are the Application segmentation covered in the Imatinib Mesylate Drugs - Market report?

Ans: The Applications covered in the Imatinib Mesylate Drugs - Market report are Hospital, Pharmacy

What are the Type segmentation covered in the Imatinib Mesylate Drugs - Market report?

Ans: The Types covered in the Imatinib Mesylate Drugs - Market report are 100mg, 400mg

Recommended Reports

Cancer Drug Markets

Targeted Therapy Drugs

Hematological Cancers

1 Market Overview

1.1 Imatinib Mesylate Drugs Product Introduction

1.2 Global Imatinib Mesylate Drugs Market Size Forecast

1.2.1 Global Imatinib Mesylate Drugs Sales Value (2019-2030)

1.2.2 Global Imatinib Mesylate Drugs Sales Volume (2019-2030)

1.2.3 Global Imatinib Mesylate Drugs Sales Price (2019-2030)

1.3 Imatinib Mesylate Drugs Market Trends & Drivers

1.3.1 Imatinib Mesylate Drugs Industry Trends

1.3.2 Imatinib Mesylate Drugs Market Drivers & Opportunity

1.3.3 Imatinib Mesylate Drugs Market Challenges

1.3.4 Imatinib Mesylate Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Imatinib Mesylate Drugs Players Revenue Ranking (2023)

2.2 Global Imatinib Mesylate Drugs Revenue by Company (2019-2024)

2.3 Global Imatinib Mesylate Drugs Players Sales Volume Ranking (2023)

2.4 Global Imatinib Mesylate Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Imatinib Mesylate Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Imatinib Mesylate Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Imatinib Mesylate Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Imatinib Mesylate Drugs

2.9 Imatinib Mesylate Drugs Market Competitive Analysis

2.9.1 Imatinib Mesylate Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Imatinib Mesylate Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 100mg

3.1.2 400mg

3.2 Global Imatinib Mesylate Drugs Sales Value by Type

3.2.1 Global Imatinib Mesylate Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Imatinib Mesylate Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Imatinib Mesylate Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Imatinib Mesylate Drugs Sales Volume by Type

3.3.1 Global Imatinib Mesylate Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Imatinib Mesylate Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Imatinib Mesylate Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Imatinib Mesylate Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global Imatinib Mesylate Drugs Sales Value by Application

4.2.1 Global Imatinib Mesylate Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Imatinib Mesylate Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Imatinib Mesylate Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Imatinib Mesylate Drugs Sales Volume by Application

4.3.1 Global Imatinib Mesylate Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Imatinib Mesylate Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Imatinib Mesylate Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Imatinib Mesylate Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Imatinib Mesylate Drugs Sales Value by Region

5.1.1 Global Imatinib Mesylate Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024)

5.1.3 Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030)

5.1.4 Global Imatinib Mesylate Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Imatinib Mesylate Drugs Sales Volume by Region

5.2.1 Global Imatinib Mesylate Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Imatinib Mesylate Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Imatinib Mesylate Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Imatinib Mesylate Drugs Sales Value, 2019-2030

5.4.2 North America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Imatinib Mesylate Drugs Sales Value, 2019-2030

5.5.2 Europe Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Imatinib Mesylate Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Imatinib Mesylate Drugs Sales Value, 2019-2030

5.7.2 South America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Imatinib Mesylate Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Imatinib Mesylate Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Imatinib Mesylate Drugs Sales Value

6.2.1 Key Countries/Regions Imatinib Mesylate Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Imatinib Mesylate Drugs Sales Value, 2019-2030

6.3.2 United States Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Imatinib Mesylate Drugs Sales Value, 2019-2030

6.4.2 Europe Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Imatinib Mesylate Drugs Sales Value, 2019-2030

6.5.2 China Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Imatinib Mesylate Drugs Sales Value, 2019-2030

6.6.2 Japan Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Imatinib Mesylate Drugs Sales Value, 2019-2030

6.7.2 South Korea Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Imatinib Mesylate Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Imatinib Mesylate Drugs Sales Value, 2019-2030

6.9.2 India Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Imatinib Mesylate Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Introduction and Business Overview

7.1.3 Novartis Imatinib Mesylate Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novartis Imatinib Mesylate Drugs Product Offerings

7.1.5 Novartis Recent Development

8 Industry Chain Analysis

8.1 Imatinib Mesylate Drugs Industrial Chain

8.2 Imatinib Mesylate Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Imatinib Mesylate Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Imatinib Mesylate Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Novartis

List of Tables

Table 1. Imatinib Mesylate Drugs Market Trends

Table 2. Imatinib Mesylate Drugs Market Drivers & Opportunity

Table 3. Imatinib Mesylate Drugs Market Challenges

Table 4. Imatinib Mesylate Drugs Market Restraints

Table 5. Global Imatinib Mesylate Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Imatinib Mesylate Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Imatinib Mesylate Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Imatinib Mesylate Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Imatinib Mesylate Drugs Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Imatinib Mesylate Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Imatinib Mesylate Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Imatinib Mesylate Drugs

Table 13. Global Imatinib Mesylate Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Imatinib Mesylate Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Imatinib Mesylate Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Imatinib Mesylate Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Imatinib Mesylate Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Imatinib Mesylate Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Imatinib Mesylate Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Imatinib Mesylate Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Imatinib Mesylate Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Imatinib Mesylate Drugs Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Imatinib Mesylate Drugs Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Imatinib Mesylate Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Imatinib Mesylate Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Imatinib Mesylate Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Imatinib Mesylate Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Imatinib Mesylate Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Imatinib Mesylate Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Imatinib Mesylate Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Imatinib Mesylate Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Imatinib Mesylate Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Imatinib Mesylate Drugs Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Imatinib Mesylate Drugs Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Imatinib Mesylate Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Imatinib Mesylate Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Imatinib Mesylate Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Imatinib Mesylate Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Imatinib Mesylate Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Imatinib Mesylate Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Imatinib Mesylate Drugs Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Imatinib Mesylate Drugs Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Imatinib Mesylate Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Imatinib Mesylate Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Imatinib Mesylate Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Novartis Company Information

Table 58. Novartis Introduction and Business Overview

Table 59. Novartis Imatinib Mesylate Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Novartis Imatinib Mesylate Drugs Product Offerings

Table 61. Novartis Recent Development

Table 62. Key Raw Materials Lists

Table 63. Raw Materials Key Suppliers Lists

Table 64. Imatinib Mesylate Drugs Downstream Customers

Table 65. Imatinib Mesylate Drugs Distributors List

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

List of Figures

Figure 1. Imatinib Mesylate Drugs Product Picture

Figure 2. Global Imatinib Mesylate Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Imatinib Mesylate Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Imatinib Mesylate Drugs Sales Price (2019-2030) & (USD/Unit)

Figure 6. Imatinib Mesylate Drugs Report Years Considered

Figure 7. Global Imatinib Mesylate Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Imatinib Mesylate Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Mesylate Drugs Revenue in 2023

Figure 10. Imatinib Mesylate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 100mg Picture

Figure 12. 400mg Picture

Figure 13. Global Imatinib Mesylate Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Imatinib Mesylate Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Imatinib Mesylate Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Imatinib Mesylate Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Imatinib Mesylate Drugs Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global Imatinib Mesylate Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Imatinib Mesylate Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Imatinib Mesylate Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Imatinib Mesylate Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Imatinib Mesylate Drugs Price by Application (2019-2030) & (USD/Unit)

Figure 25. North America Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Imatinib Mesylate Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Imatinib Mesylate Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Imatinib Mesylate Drugs Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Imatinib Mesylate Drugs Sales Volume (%), (2019-2030)

Figure 37. United States Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. China Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. China Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. India Imatinib Mesylate Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Imatinib Mesylate Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. India Imatinib Mesylate Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. Imatinib Mesylate Drugs Industrial Chain

Figure 59. Imatinib Mesylate Drugs Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Imatinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gleevec Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Imatinib Mesylate Market Research Report 2024

Imatinib Mesylate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Treatment Drugs Market

Alectinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nilotinib Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dasatinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemotherapy Drug Market Insights Forecast to 2030

Sarcoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030

Global Stomach Cancer Drugs Market Insights Forecast to 2030

Enasidenib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Small Molecule Drugs Market Insights Forecast to 2030

Rituximab Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arranon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions